Clinical Trial Update: Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study using pharmacogenetics to guide treatment for head and neck cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Georgetown University | Conditions: Head and Neck Cancer | Phase 2 | Status: WITHDRAWN